OR WAIT null SECS
August 04, 2021
Bristol Myers Squibb has been granted approval by the European Commission for Opdivo (nivolumab) as an adjuvant treatment
Bioiberica has received certification of its CSR management system as aligned with the United Nations Sustainable Development Goals.
Sanofi has acquired Translate Bio in a bid to further their mRNA research.
August 03, 2021
DisperSol and Catalent announce manufacturing collaboration to accelerate DisperSol’s pharmaceutical production.
August 02, 2021
Regeneron and AstraZeneca have entered an agreement to create a small-molecule medicine designed to treat obesity.
July 30, 2021
Emergent BioSolutions is being allowed to restart manufacturing operations for the J&J COVID-19 vaccine at its Bayview, Baltimore, Md., facility.
VICO Therapeutics’ drug candidate, VO659, for treating Huntington’s Disease was granted orphan drug designation by FDA.
July 29, 2021
Thermo Fisher Scientific has added a new suite of immune repertoire assays that offers high detection rates of malignant clones, allowing researchers to better assess blood cancers.
ERS Genomics and Japan SLC have signed a non-exclusive license agreement, allowing Japan SLC access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
Summa Equity has acquired a majority stake in science tools business Axion BioSystems with the intent of further entering the CGT market.